National Research Co. (NASDAQ:NRCIA) – Research analysts at William Blair upped their Q1 2018 earnings per share (EPS) estimates for National Research in a report issued on Tuesday. William Blair analyst R. Daniels now anticipates that the business services provider will post earnings of $0.29 per share for the quarter, up from their prior forecast of $0.25. William Blair also issued estimates for National Research’s Q2 2018 earnings at $0.26 EPS, Q3 2018 earnings at $0.27 EPS, Q4 2018 earnings at $0.29 EPS, Q1 2019 earnings at $0.32 EPS, Q2 2019 earnings at $0.28 EPS, Q3 2019 earnings at $0.30 EPS, Q4 2019 earnings at $0.31 EPS and FY2019 earnings at $1.21 EPS.
NRCIA has been the subject of a number of other reports. BidaskClub raised shares of National Research from a “hold” rating to a “buy” rating in a research note on Friday, January 26th. Zacks Investment Research raised shares of National Research from a “sell” rating to a “hold” rating in a research note on Tuesday, February 6th.
In related news, CEO Michael D. Hays sold 1,602,399 shares of the stock in a transaction dated Thursday, January 25th. The shares were sold at an average price of $39.03, for a total value of $62,541,632.97. Following the completion of the transaction, the chief executive officer now directly owns 5,261,410 shares of the company’s stock, valued at $205,352,832.30. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 37.54% of the stock is owned by corporate insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in NRCIA. Citigroup Inc. grew its holdings in National Research by 120.2% in the second quarter. Citigroup Inc. now owns 8,299 shares of the business services provider’s stock worth $224,000 after purchasing an additional 4,531 shares during the period. The Manufacturers Life Insurance Company grew its holdings in National Research by 252.1% in the second quarter. The Manufacturers Life Insurance Company now owns 9,090 shares of the business services provider’s stock worth $244,000 after purchasing an additional 6,508 shares during the period. Goldman Sachs Group Inc. grew its holdings in National Research by 58.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 8,412 shares of the business services provider’s stock worth $314,000 after purchasing an additional 3,094 shares during the period. Alliancebernstein L.P. grew its holdings in National Research by 5.1% in the second quarter. Alliancebernstein L.P. now owns 12,369 shares of the business services provider’s stock worth $333,000 after purchasing an additional 600 shares during the period. Finally, Wells Fargo & Company MN grew its holdings in shares of National Research by 75.2% during the third quarter. Wells Fargo & Company MN now owns 9,450 shares of the business services provider’s stock valued at $356,000 after buying an additional 4,056 shares during the last quarter. Institutional investors and hedge funds own 25.40% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2018/02/15/q1-2018-eps-estimates-for-national-research-co-increased-by-analyst-nrcia.html.
About National Research
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.